Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Oct 01, 2026
Micron Technology (MU) Reports Record Fiscal Q4 Revenue on AI Demand

Micron Technology (MU) Reports Record Fiscal Q4 Revenue on AI Demand

Key Takeaways

  • Micron reported record fiscal Q4 2026 revenue of $54.2 billion, up 379% year over year, beating the roughly $51.1 billion consensus estimate.
  • Non-GAAP diluted earnings per share (EPS) reached $33.42, above analyst expectations of about $31.61.
  • Gross margin climbed to 87%, a sharp increase from 45.7% in the year-ago quarter.
  • Full-year fiscal 2026 revenue hit $133.2 billion, up 256%, with non-GAAP diluted EPS of $75.52.
  • Guidance for fiscal Q1 2027 calls for revenue of $61.5 billion and EPS of $38.15, both ahead of consensus.
  • Shares finished the regular session roughly flat, with strong results appearing largely priced in.

Why These Results Stand Out

Micron Technology is one of the largest producers of memory and storage chips, including DRAM and NAND flash. Its performance serves as a useful indicator for the semiconductor sector and the ongoing buildout of artificial intelligence infrastructure. The company had already delivered record revenue in each of the previous five quarters. With high-bandwidth memory demand remaining robust and industry supply staying constrained, this update provided another data point on the durability of the current memory cycle.

The Quarter in Detail

Micron reported fiscal fourth-quarter 2026 revenue of $54.23 billion, a record and a 379% increase from $11.32 billion a year earlier. That figure surpassed the consensus estimate of roughly $51.07 billion. Non-GAAP diluted EPS came in at $33.42, above the approximately $31.61 analysts expected. On a GAAP basis, net income was $37.70 billion, or $32.87 per diluted share.

Profitability improved markedly, with gross margin reaching 87%, up from 45.7% in the year-ago period and from 84.9% in the prior quarter. DRAM revenue totaled $39.8 billion, or 73% of sales, while NAND revenue reached $14.1 billion, or 26%. Data center SSD revenue alone approached $10 billion, more than ten times the year-ago figure. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

For the full fiscal year, revenue was $133.2 billion, up 256%, with non-GAAP diluted EPS of $75.52. Micron also highlighted 26 signed Strategic Customer Agreements covering more than 35% of revenue through 2030, with roughly $32 billion in customer financial commitments.

Looking ahead, the company guided fiscal Q1 2027 revenue to $61.5 billion (plus or minus $1.5 billion) and non-GAAP diluted EPS to $38.15 (plus or minus $1.00), both above consensus. Management expects gross margin of approximately 86.25% for the quarter.

Market Reaction

The market response to the strong results was relatively muted. Shares closed the regular session roughly flat and moved only modestly in after-hours trading, despite revenue, EPS, and forward guidance all exceeding expectations. Analysts noted that much of the exceptional momentum had already been reflected in the stock price after a period of steep gains. Investor sentiment remains generally positive, with attention focused on sustained tight memory supply and AI-related demand, though some observers are watching how much further upside is already priced in.

Looking Ahead

Micron indicated that fiscal 2027 is expected to be another record year, with sequential revenue growth projected in every quarter. Gross margin is anticipated to be approximately 86.25% in fiscal Q1 2027 and is viewed as a likely floor for the year. Higher costs related to incentive compensation and fab startup expenses are expected to pressure near-term profitability, even as pricing power stays firm.

Investors will want to track the supply-demand balance in DRAM and NAND. The company expects the industry to remain supply-constrained through calendar 2027 and 2028, though shifts in AI infrastructure spending or faster capacity additions by competitors could change that picture.

Capital allocation and manufacturing expansion will also merit attention. Micron plans higher capital expenditures in fiscal 2027, primarily to add cleanroom space, and has signaled a possible return to share buybacks once CHIPS Act-related restrictions ease. Balancing heavy investment with returns to shareholders will likely remain a key theme.

My Research Process

One tool I frequently turn to when analyzing semiconductor names is Tickeron’s AI Screener. It helps filter the market by technical patterns, fundamentals, and performance metrics, which can be useful for spotting related opportunities across the sector after a report like this one.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MU

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


MU in upward trend: 10-day moving average moved above 50-day moving average on September 03, 2026

The 10-day moving average for MU crossed bullishly above the 50-day moving average on September 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 17, 2026. You may want to consider a long position or call options on MU as a result. In 63 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.

The Moving Average Convergence Divergence (MACD) for MU just turned positive on September 18, 2026. Looking at past instances where MU's MACD turned positive, the stock continued to rise in 34 of 49 cases over the following month. The odds of a continued upward trend are 69%.

MU moved above its 50-day moving average on September 15, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where MU advanced for three days, in 260 of 329 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

The Aroon Indicator entered an Uptrend today. In 256 of 313 cases where MU Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 82%.

Bearish Trend Analysis

The 10-day RSI Indicator for MU moved out of overbought territory on September 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 50 similar instances where the indicator moved out of overbought territory. In 34 of the 50 cases, the stock moved lower in the following days. This puts the odds of a move lower at 68%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.

MU broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 3 (best 1 - 100 worst), indicating outstanding price growth. MU’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 17 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 18 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 31 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.820) is normal, around the industry mean (7.811). P/E Ratio (23.824) is within average values for comparable stocks, (160.549). Projected Growth (PEG Ratio) (0.154) is also within normal values, averaging (3.705). Dividend Yield (0.001) settles around the average of (0.006) among similar stocks. P/S Ratio (11.696) is also within normal values, averaging (44.558).

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Broadcom Inc. (NASDAQ:AVGO), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Marvell Technology (NASDAQ:MRVL), QUALCOMM (NASDAQ:QCOM), Analog Devices (NASDAQ:ADI).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 213.1B. The market cap for tickers in the group ranges from 86.8K to 5.53T. NVDA holds the highest valuation in this group at 5.53T. The lowest valued company is STRB at 86.8K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was 0%. For the same Industry, the average monthly price growth was 11%, and the average quarterly price growth was 55%. MX experienced the highest price growth at 17%, while CBRS experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was 10%. For the same stocks of the Industry, the average monthly volume growth was -1% and the average quarterly volume growth was -49%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 51
Price Growth Rating: 44
SMR Rating: 72
Profit Risk Rating: 72
Seasonality Score: 18 (-100 ... +100)
View a ticker or compare two or three
MU
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of advanced semiconductor solutions such as DRAMs, NAND flash memory, CMOS image sensors, other semiconductor components and memory modules

Industry Semiconductors

Industry
Semiconductors
Address
8000 S. Federal Way
Phone
+1 208 368-4000
Employees
53000
Web
https://www.micron.com
Interact to see
Advertisement
MRSH stock declined approximately -9% over the past 30 days, driven by sector-wide AI disruption fears and analyst downgrades. Over the past quarter, the stock fell around -7%, amid softening insurance rates and declining fiduciary interest income.
MCO stock declined approximately -9% over the last 30 days amid profit-taking, insider selling, and sector-wide concerns in financial data analytics. Over the past quarter, shares fell around -18%, reflecting a correction from January highs despite strong Q4 2025 earnings. Key drivers include post-earnings selloff after Q4 results, analyst price target cuts, and broader market volatility in credit ratings sector.
SNOW stock declined approximately -9% over the last 30 days, from around $168 to $153, amid post-earnings profit-taking and analyst caution despite strong results. Over the past quarter, the stock fell about -31%, from near $223, reflecting broader sector pressures and valuation concerns in cloud software.
WDS stock surged +24% over the past 30 days, driven by a sharp rally in oil and LNG prices amid Middle East supply disruptions, including Strait of Hormuz issues and strikes on Qatar's Ras Laffan facility. Over the past quarter, the stock climbed +55%, reflecting sustained energy market volatility and Woodside's strong production from assets like Sangomar and Pluto LNG.
HMC stock declined -19% over the past 30 days amid major setbacks in EV strategy, including cancellation of North American EV models and up to $15.7 billion in related losses. Over the past quarter, shares fell -18%, driven by persistent auto segment weakness, tariff impacts, and revised FY2026 forecasts to a net loss. Key catalysts include March EV reassessment announcement causing a 5%+ drop, Q3 earnings beat overshadowed by one-time charges and guidance concerns, and Sony-Honda JV EV project halt.
EL stock plunged approximately -39% over the past 30 days amid merger discussions with Puig, tariff pressures, and restructuring costs, marking a highly volatile period. Over the past quarter, the stock is down around -37%, reflecting broader sector headwinds despite earlier quarterly earnings beats. Key drivers include confirmation of potential business combination with Puig sparking uncertainty, ongoing $100 million tariff impacts, and elevated restructuring expenses.
ESLT stock rose +13% over the past 30 days, driven primarily by a blowout Q4 2025 earnings report with revenue up 11% and EPS beating estimates by over 10%. Over the past quarter, shares surged +52%, fueled by a record $28.1 billion order backlog, up significantly year-over-year, amid heightened global defense demand. Geopolitical tensions in the Middle East boosted demand for Elbit's systems, alongside major contract wins totaling hundreds of millions from international clients.
EQT stock rose approximately +10% over the last 30 days, driven by strong Q4 2025 earnings beat, robust free cash flow guidance for 2026, and analyst price target increases. Over the past quarter, shares gained around +23%, fueled by operational efficiencies, natural gas price recovery, and positive sector sentiment amid LNG demand growth.
Robin Energy Ltd is a Cyprus-based shipping company focused on ocean and deep-sea freight transportation. As a holding entity, it acquires, owns, charters, and manages oceangoing tanker vessels worldwide. The core of its business lies in energy transportation services, mainly through handysize tankers and LPG carriers. In the competitive marine shipping industry, RBNE positions itself as a growth-oriented player, expanding its fleet and locking in multi-year charters. Recent developments, such as vessel acquisitions and Bitcoin treasury allocations, leave it exposed to shipping cycles and alternative asset volatility. From what I see, this mix contributes to the erratic stock price behavior we've observed amid shifting global energy demand and freight rates.
NG stock plunged -42% over the past 30 days amid sharp declines from mid-March peaks around $14, driven by profit-taking after a multi-year rally and sector-wide weakness in gold mining stocks. Over the past quarter, the stock is down -14%, reflecting volatility from early-year gains tied to financing successes offset by recent macro pressures and permitting concerns. Key drivers include gold price fluctuations due to interest rate expectations, profit-taking post-240%+ annual surge, and no immediate production revenue despite Donlin Gold project advancements.
CRBU stock declined approximately -10% over the past 30 days, reflecting volatility amid clinical updates and financing concerns. Over the past quarter, the stock rose about +12%, driven by positive earnings beats and pipeline progress. Key drivers include Q4 2025 earnings beat, vispa-cel Phase 3 plans, but offset by cash burn and need for additional capital.
Shares of Viridian Therapeutics (VRDN) are down approximately 32% in premarket trading on March 30, 2026, against a prior closing price of $27.39 on March 27, 2026, implying a premarket price near $18.63. The primary catalyst is the release of topline Phase 3 REVEAL-1 clinical trial data for elegrobart (VRDN-003) in patients with active thyroid eye disease (TED), long anticipated as the company's most critical near-term de-risking event.
SYY shares are trading approximately -6.40% lower in premarket trading on March 30, 2026, from a prior close of $81.80 to roughly $76.56. The primary catalyst is Sysco's announcement of a $29.1 billion definitive agreement to acquire Jetro Restaurant Depot, one of the nation's largest Cash & Carry food wholesalers.
Northwest Biotherapeutics, Inc. (NWBO) is a clinical-stage biotechnology company focused on developing personalized immune therapies, primarily dendritic cell-based vaccines under its DCVax platform. The company's lead candidate, DCVax-L, targets glioblastoma multiforme (GBM), a lethal brain cancer, following completion of a Phase III trial. DCVax-Direct addresses inoperable solid tumors, with Phase I/II data available. NWBO operates in the competitive immunotherapy sector against players like large-cap biotechs, relying on a proprietary manufacturing process for cost-effective production.
FingerMotion, Inc. (FNGR) operates as a mobile data specialist, delivering mobile payment and recharge platform solutions mainly in China. The company's core revolves around telecommunication products and services, such as top-up recharges, data plans, SMS and MMS services, big data insights for consumer behavior analysis, and rich communication services (RCS) platforms. It also provides value-added products through partnerships with telecom providers and e-commerce platforms.
NIO Inc. (NIO) stands out as a leading Chinese electric vehicle manufacturer focused on premium smart EVs. The company designs, develops, and sells high-end battery electric vehicles, bolstered by its Battery-as-a-Service model that lets customers swap batteries at stations rather than owning them. In the cutthroat Chinese EV space, NIO competes directly with firms like XPEV and LI.
Xcel Energy Inc. (XEL) stands out as a major U.S. electric and natural gas utility, serving about 3.7 million electric and 2.2 million natural gas customers across eight states, mainly in the Midwest and West. The company focuses on regulated utilities, handling electricity generation, transmission, and distribution, while increasingly prioritizing renewable sources like wind and solar. Its model centers on steady, regulated returns from infrastructure investments, backed by rate cases and recovery mechanisms.
Occidental Petroleum Corporation (OXY) stands out as a leading independent energy producer, with a primary focus on hydrocarbon exploration and production. The company has significant operations in the Permian Basin, one of the U.S.'s most productive oil regions, along with assets in the Rockies, Latin America, and the Middle East. Its business model emphasizes efficient drilling, low-cost production, and carbon capture initiatives aimed at long-term sustainability.
The ProShares UltraShort Bloomberg Natural Gas (KOLD) is a leveraged inverse exchange-traded fund that seeks daily investment results, before fees and expenses, corresponding to two times the inverse (-2x) of the daily performance of the Bloomberg Natural Gas Subindex. This subindex reflects the natural gas segment of the commodities market by tracking futures contracts, primarily the second-month Henry Hub natural gas futures, weighted by liquidity and production. The fund does not invest directly in physical natural gas but uses derivatives like futures contracts and swaps to achieve its objective.
Shares of United Therapeutics (UTHR) are surging approximately +17% in premarket trading on Monday, March 30, 2026, with the market not yet open. The primary catalyst is a landmark Phase 3 clinical trial announcement: the TETON-1 pivotal study of nebulized Tyvaso® (treprostinil) met its primary endpoint for treating idiopathic pulmonary fibrosis (IPF), exceeding the already impressive treatment effects seen in the previously completed TETON-2 study.